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Abstract
Background: Advanced age is associated with immunosenescence as well as increased risk
for poor outcomes during episodes of community-acquired pneumonia (CAP). Data on neutrophil
function in hospitalized elderly patients with CAP is lacking. In this study we compared neutrophil
function in elderly and non-elderly hospitalized patients with CAP.
Methods: Prospective study of healthy controls (HC) and patients hospitalized with CAP non-
elderly (NE-CAP) and elderly (E-CAP). Blood samples were obtained on the day of hospitalization.
The following neutrophil functional assays were performed: degranulation of secretory vesicles
(CD35), degranulation of specific granules (CD66b), phagocytosis, and hydrogen peroxide (H2O2)
production. The Mann-Whitney U-test was used to compare differences in neutrophil function.
Results: A total of 12 HC, 28 NE-CAP, and 12 E-CAP were evaluated. There were no signifi-
cant differences between NE-CAP and E-CAP patients in regard to CD35 expression (p=0.465),
CD66b expression (p=0.601), phagocytosis (p=0.654), or H2O2 production (p=0.541)
Conclusions: We failed to demonstrate any significant difference in neutrophil function in non-
elderly versus elderly patients hospitalized with CAP in relation to membrane expression of CD35
and CD66b, phagocytosis, and respiratory burst. Abnormal neutrophil function is unlikely to be an
important component of the immunosenescence described in elderly patients with CAP.
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1 Background
Elderly patients with community-acquired pneumonia (CAP) are
at increased risk for poor clinical outcomes when compared to
non-elderly patients. Advanced age is an independent risk factor
for mortality present in several of the CAP severity scores1. Hu-
man aging is associated with a gradual decrease of immune func-
tion, defined as immunosenescence2. In the elderly, immunose-
nescence affects innate and adaptive immune responses. This
may explain the increased susceptibility of the elderly to develop
CAP, as well as the increased morbidity and mortality in these
patients3.
Neutrophils are the primary effector cells of the innate response
and are the first line of defense against bacteria multiplying in
the lung. During an episode of CAP, neutrophils recognize and
bind immunoglobulin G molecules and complement proteins that
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coat the surface of bacteria in the alveoli. After binding to bac-
teria, killing is achieved by phagocytosis, the fusion of phago-
somes with intracellular secretory granules, followed by degranu-
lation and respiratory burst4–6. Even though there is a significant
body of literature defining neutrophil function for several human
conditions, none of these critical neutrophil functions have been
characterized in patients with CAP.
Considering the importance of neutrophil function in the innate
immune response during an episode of CAP and the poor clinical
outcomes of CAP in the elderly, we hypothesized that decreased
neutrophil function may be an important contributor to the im-
munosenescence described in the elderly. To test this hypothesis
we compared neutrophil function in elderly and non-elderly hos-
pitalized patients with CAP.
2 Methods
2.1 Study design and participants
This was a prospective observational study of hospitalized pa-
tients with CAP as well as healthy controls. Patients hospitalized
with CAP were enrolled at the University of Louisville Hospital
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Table 1 Baseline characteristics of hospitalized patients with community-acquired pneumonia
Elderly (≥ 65) Non-Elderly (<65)
Variable n = 12 n (%) p-value
n = 28 n (%)
Demographics
Age, median (IQR) 78.5 (9) 53 (9.5)
Male Gender 11 (92) 23 (82) 0.648
Past Medical History
Smoking 0 (0) 16 (57) 0.001
Neurologic Diseases 1 (8) 2 (7) 1
Cerebrovascular Diseases 4 (33) 2 (7) 0.06
CHF 7 (58) 6 (22) 0.062
COPD 7 (58) 7 (26) 0.075
Diabetes mellitus 7 (58) 5 (19) 0.023
HIV 0 (0) 3 (11) 0.541
Acute Renal Diseases 2 (17) 1 (4) 0.229
Chronic Renal Diseases 3 (25) 2 (7) 0.159
Hepatic Diseases 0 (0) 2 (7) 1
Neoplastic Diseases 3 (25) 1 (4) 0.078
Hyperlipidemia 9 (75) 6 (21) 0.003
Statin Therapy 5 (42) 6 (21) 0.254
Immunosuppression 3 (25) 4 (14) 0.41
Vaccination History
Previous Influenza vaccine 6 (50) 4 (14) 0.041
Previous Pneumococcal vaccine 8 (67) 5 (18) 0.008
Clinical, Laboratory and Radiological Findings
Alter Mental Status 2 (17) 1 (4) 0.209
Pleural Effusion 4 (33) 8 (29) 1
ICU Admission 5 (42) 8 (29) 0.476
Fever (Temp ≥ 100◦F) 5 (41.7) 16 (57.1) 0.580
White Blood Cell Count, Median (IQR) 14.0 (5.4) 11.4 (5.8) 0.092
Healthcare-Associated Pneumonia (HCAP) 3 (25) 7 (25) 1
Pneumonia Severity Index (PSI) ≥ 4 10 (83) 12 (43) 0.035
S. pneumoniae 4 (33) 5 (18) 0.411
Macrolide Therapy 4 (33) 10 (36) 1
Early Time to Clinical Stability (< 3 days) 7 (58) 19 (68) 0.72
and the Robley Rex Veterans Affairs Medical Center of Louisville
from March 2011 to January 2012. The University of Louisville
Human Subjects Program Protection Office and the Robley Rex
Veterans Affairs Medical Center Institutional Review Boards ap-
proved this study prior to any data collection (Approvals #:
07.0182 and 0009, respectively).
2.2 Definition of CAP in the elderly
A patient was considered to have CAP if there was evidence of
a new pulmonary infiltrate at chest radiograph at time of hos-
pitalization plus at least one of the following criteria: 1) new
or increased cough; 2) fever (>100◦F) or hypothermia (<96◦F);
3) changes in white blood cell count (leukocytosis, left shift, or
leukopenia). A patient was defined as elderly if his/her age was
≥65 years.
2.3 Definition of healthy controls
Healthy controls were defined as blood donors meeting the fol-
lowing criteria: 1) negative history for chronic medical condi-
tions, 2) not currently pregnant, 3) asymptomatic during the
week previous to blood collection, and 4) not currently taking
prescription or over-the-counter medication. Laboratory meth-
ods: Blood samples were obtained from CAP patients on the day
of hospital admission. Venous blood was collected using sodium
citrate Vacutainer R©tubes. Following centrifugation at 300 × g
for 10 min, the plasma was separated by aspiration, aliquoted
and stored frozen at -80◦C until assayed. The same process was
followed for healthy control blood samples.
2.4 Neutrophil functional assays
Degranulation of secretory vesicles (CD35) and specific gran-
ules (CD66b) was determined by measuring plasma membrane
expression, using flow cytometry. After incubation of whole
blood with and without formyl-methionyl-leucyl phenylalanine
for 5 min at 37◦C, an ice-cold solution containing antibody
FITC-conjugated monoclonal anti-CD35 or FITC-conjugated mon-
oclonal anti-CD66b were added and the samples immediately
placed at room temperature in the dark for 30 min. FITC-
conjugated mouse IgG1 and PE-conjugated mouse IgG1 were
used as an isotype controls respectively. At the end of the in-
cubation time the samples were mixed with lysis buffer, and in-
cubated for 5 min at room temperature (RT), after which they
were washed two times with 0.1% sodium azide and then resus-
pended in 1% paraformaldehyde, before being analyzed for fluo-
rescence intensity by flow cytometry (mean channel fluorescence)
on a FACSCalibur instrument (Becton Dickinson, Franklin Lakes,
NJ). To measure phagocytosis and hydrogen peroxide produc-
tion in phagosomes, whole blood samples were incubated with
dichlorofluorescin diacetate for 10 min at 37◦C. Fifty microliters
of whole blood was sampled before, and 10 min later, the addition
of 50 ml of opsonized, propidium iodide-labeled Staphylococcus
aureus (final concentration 108 bacteria/ml). At the end of the
incubation time, samples were mixed with lysis buffer, and allow
to sit for 5 min at RT. The samples were then washed twice with
0.1% sodium azide, resuspended in 1% paraformaldehyde, and
analyzed for fluorescence intensity by flow cytometry, excluding
mononuclear cells.
2.5 Study groups and statistical analysis
Neutrophil function was evaluated for healthy controls (study
group 1), hospitalized non-elderly patients with CAP (study group
2), and hospitalized elderly patients with CAP (study group 3).
The Mann-Whitney U-test was used to compare differences in
ULJRI 2017 Vol 1, (1) 12–16 | 13
Fig. 1 Neutrophils plasma membrane expression of CD35 under baseline conditions and after stimulation with formyl-methionyl-leucyl phenylalanine
(fmlf) for each of the study groups.
Fig. 2 Neutrophils plasma membrane expression of CD66b under baseline conditions and after stimulation with formyl-methionyl-leucyl phenylalanine
(fmlf) for each study group.
neutrophil function between healthy controls (group 1) and hos-
pitalized patients with CAP (groups 2 and 3 combined) as well as
between non-elderly (group 2) and elderly (group 3) hospitalized
patients with CAP.
3 Results
Neutrophil function was evaluated in 52 study participants, 12
healthy controls, 28 non-elderly hospitalized patients with CAP,
and 12 elderly patients hospitalized with CAP. The baseline char-
acteristics of non-elderly and elderly hospitalized patients with
CAP are depicted in Table 1.
The neutrophil plasma membrane expression of CD35 under
baseline conditions and after stimulation with formyl-methionyl-
leucyl phenylalanine is depicted in Figure 1. A statistically sig-
nificant increase in CD35 expression was seen for all CAP pa-
tients when compared to healthy donors under unstimulated and
stimulated conditions (p<0.001 each). There were no significant
differences in CD35 expression for non-elderly versus elderly pa-
tients with CAP under basal conditions (p=0.465) or after stimu-
lation (p=0.846).
The plasma membrane expression of CD66b in neutrophils under
baseline conditions and after stimulation with formyl-methionyl-
leucyl phenylalanine is depicted in Figure 2. There were no dif-
ferences between CD66b expression for all CAP patients versus
healthy donors in unstimulated conditions (p=0.080), however a
statistically significant increase in CD66b expression was seen for
all CAP patients when compared to healthy donors under stim-
ulated conditions (p<0.001). There were no significant differ-
ences in CD66b expression for non-elderly versus elderly patients
with CAP under basal conditions (p=0.601) or after stimulation
(p=0.629).
The neutrophil phagocytosis of opsonized propidium iodide-
labeled Staphylococcus aureus for healthy donors, non-elderly hos-
pitalized patients with CAP, and elderly hospitalized patients with
CAP are depicted in Figure 3. No statistically significant dif-
ferences were demonstrated among the study groups (CAP vs
healthy p=0.288; CAP non-elderly vs elderly p=0.654).
The neutrophil hydrogen peroxide production in phagosomes for
healthy donors, non-elderly hospitalized patients with CAP, and
elderly hospitalized patients with CAP are depicted in Figure 4. A
statistically significant increase in hydrogen peroxide production
was demonstrated for CAP patients when compared to healthy
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Fig. 3 Neutrophils phagocytosis of opsonized propidium iodide-labeled Staphylococcus aureus for each study group.
Fig. 4 Neutrophils hydrogen peroxide production in phagosomes for each of the study groups.
donors (p<0.001). There were no statistically significant differ-
ences in hydrogen peroxide production in non-elderly versus el-
derly hospitalized patients with CAP (p=0.541).
4 Discussion
In this study we failed to demonstrate any significant difference
in neutrophil function in non-elderly versus elderly patients hos-
pitalized with CAP in relation to membrane expression of CD35
and CD66b, phagocytosis, and respiratory burst.
Prior studies have documented that neutrophil precursors in the
bone marrow, as well as the number of neutrophils present in
the systemic circulation are not different in non-elderly and el-
derly adults7,8. Neutrophil chemotaxis is important to bring neu-
trophils from the pulmonary circulation into the alveoli. The
process of neutrophil chemotaxis has been shown to be unaf-
fected by age9. Once neutrophils migrate to the alveoli, the ini-
tial recognition and binding of opsonized bacteria is mediated by
neutrophil surface receptors, including the complement receptor
CR1 or CD3510. Degranulation of secretory vesicles and degranu-
lation of specific granules are important neutrophil functions that
are associated with membrane expression of CD35 and CD66b10.
In our study, the expression of these membrane markers was sim-
ilar in circulating neutrophils of non-elderly and elderly hospital-
ized patients with CAP. However, these two groups of CAP pa-
tients have a significant increase in the membrane markers CD35
and CD66b when compared to healthy controls after stimulation
with formyl-methionyl-leucyl phenylalanine. This suggests that
after maturation and release from the bone marrow, neutrophils
of hospitalized patients with CAP are already primed in the pe-
ripheral circulation, and are ready to express membrane receptors
once they arrive to the lung.
In our study we use opsonized propidium iodide-labeled Staphy-
lococcus aureus as a marker of phagocytosis. These results indicate
that the phagocytic ability of circulating neutrophils against S. au-
reus is not affected by age. Our data suggests that the phagocytic
ability of circulating neutrophils in hospitalized patients with CAP
is similar to that of healthy controls. It has been suggested that
neutrophil phagocytosis may be pathogen specific. The fact that
we found normal phagocytosis of S. aureus and a prior study in-
dicated a reduced neutrophil phagocytosis of E. coli in elderly
donors supports this concept4.
After phagocytosis, stimulation of the respiratory burst with rapid
release of reactive oxygen species is a crucial step for bacterial
killing. In our study, we used production of hydrogen peroxide in
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phagosomes as a marker of respiratory burst. We demonstrated
that the level of phagocytosis stimulated respiratory burst is not
decreased in non-elderly patients when compared to elderly pa-
tients with CAP. Our data is concordant with prior reports indi-
cating that superoxide generation is not affected in neutrophils
obtained from elderly donors4.
The current study has several limitations. First, we only evalu-
ated a limited number of hospitalized patients with CAP, which
limits generalizability of our results. Second, we compared neu-
trophil function only in circulating neutrophils, but the activity
of circulating neutrophils may not be a complete reflection of the
activity of neutrophils once they migrate to the alveoli. Third, we
evaluated the neutrophil membrane expression of two primary
molecules, CD35 and CD66b, but neutrophils in elderly patients
with CAP may fail to express other membrane receptors not eval-
uated in our study. Fourth, other neutrophil functions that may be
associated with poor clinical outcomes, such as type of cell death,
were not evaluated. Neutrophil death may occur in the form of
apoptosis, netosis, pyroptosis, or necrosis11. Apoptosis and neto-
sis are non-inflammatory programmed cell death types associated
to beneficial effects. On the other hand, pyroptosis and necrosis
are associated with increased inflammation that, in turn, may fa-
vor tissue damage and worse clinical outcomes12.
Some aspects of neutrophil function in patients with CAP can be
evaluated in neutrophils obtained from bronchoalveolar lavage
samples as well as sputum samples. Our group recently reported
an evaluation of neutrophil apoptosis from neutrophils obtained
from sputum samples in a hospitalized patient with influenza
CAP13. Future studies using these respiratory samples may give
us a better understanding of neutrophil function at the alveolar
level in hospitalized patients with CAP.
Beyond the pilot design, our study limitations include the assess-
ment of neutrophil functions from the patient hospital admission
day only and this assessment was in-vitro only.
In conclusion, this study demonstrates that some of the most criti-
cal neutrophil functions in patients with CAP are not decreased in
the elderly, suggesting that abnormal neutrophil function is un-
likely to be an important component of the immunosenescence
described in elderly patients with CAP.
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